Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 48, Issue 3, 2007, Pages 349-353

  Barfield, R C ^a   Hale, G A ^a   Burnette, K ^a   Behm, F G ^a   Knapp, K ^a   Eldridge, P ^a   Handgretinger, R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

ALL relapse; Infectious disease; Stem cell transplantation; Tumor markers

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ASPARAGINASE; CASPOFUNGIN; CD133 ANTIGEN; CD34 ANTIGEN; DEXAMETHASONE; ETOPOFOS; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; POSACONAZOLE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; LUNG BIOPSY; MALE; MUCORMYCOSIS; PRIORITY JOURNAL;

6-MERCAPTOPURINE; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; COMBINED MODALITY THERAPY; DEXAMETHASONE; DRUG THERAPY, COMBINATION; GLYCOPROTEINS; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; METHOTREXATE; PEPTIDES; PEPTIDES, CYCLIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PYRIMIDINES; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TRIAZOLES; VINCRISTINE; ZYGOMYCOSIS;

EID: 33846905969     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20687     Document Type: Article

References (15)

1. Wali YA, Al LZ, al KH, et al. Case report. Successful outcome of invasive nasal sinus zygomycosis in a child with relapsed acute lymphoblastic leukaemia due to liposomal amphotericin B. Mycoses 2001;44:195-199.
2. Parkyn T, McNinch AW, Riordan T, et al. Zygomycosis in relapsed acute leukaemia. J Infect 2000;41:265-268.
3. Imai Y, Chou T, Tobinai K, et al. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: Purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): Results of Japanese phase II study. Bone Marrow Transplant 2005;35:479-487.
4. Alvarnas JC, Forman SJ. Graft purging in autologous bone marrow transplantation: A promise not quite fulfilled. Oncology (Williston Park) 2004;18:867-876.
5. Koehl U, Zimmermann S, Esser R, et al. Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia. Bone Marrow Transplant 2002;29:927-930.
6. Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-226.
7. Gu Z, Belzer SW, Gibson CS, et al. Multiplexed, real-time PCR for quantitative detection of human adenovirus. J Clin Microbiol 2003;41:4636-4641.
8. Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999;37:132-136.
9. Brenner MK, Rill DR, Moen RC, et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85-86.
10. Dal CL, Cottu PH, Lotz JP, et al. Residual tumor cell contamination in peripheral blood stem cells collections of 117 breast cancer patients evaluated by immunocytochemical technique. J Hematother Stem Cell Res 2001;10:855-862.
11. Handgretinger R, Lang P, Schumm M, et al. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 1998;21:987-993.
12. Buhring HJ, Seiffert M, Marxer A, et al. AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors. Blood 1999;94:832-833.
13. Horn PA, Tesch H, Staib P, et al. Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells. Blood 1999;93:1435-1437.
14. Najvar LK, Cacciapuoti A, Hernandez S, et al. Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: Comparative studies in two laboratories. Antimicrob Agents Chemother 2004;48:758-764.
15. Dannaoui E, Meletiadis J, Mouton JW, et al. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003;51:45-52.